119
Participants
Start Date
November 30, 2013
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
Intravenous Acetaminophen
Participants randomized to intravenous acetaminophen (Ofirmev) will receive an infusion of Ofirmev in 100 ml of 0.9 NS according to manufacturer's recommendations related to subject's weight.
Placebo (0.9% Normal Saline infusion)
Infusion of 100 ml of 0.9% NS
Florida Hospital Celebration Health, Celebration
Lead Sponsor
University of Central Florida
OTHER
AdventHealth
OTHER